Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Research article

Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional study

Davis Kibirige1*, Richard Ssekitoleko23, Edrisa Mutebi24 and William Worodria25

Author Affiliations

1 Department of Medicine, St. Raphael of St. Francis hospital Nsambya, P.O.BOX 7146, Kampala, Uganda

2 Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda

3 Infectious diseases unit, Mulago National referral and Teaching Hospital, Kampala, Uganda

4 Endocrine unit, Mulago National referral and Teaching Hospital, Kampala, Uganda

5 Pulmonology unit, Mulago National referral and Teaching Hospital, Kampala, Uganda

For all author emails, please log on.

BMC Infectious Diseases 2013, 13:122  doi:10.1186/1471-2334-13-122

Published: 5 March 2013

Abstract

Background

There is a documented increase of diabetes mellitus in Sub Saharan Africa, a region where tuberculosis is highly endemic. Currently, diabetes mellitus is one of the recognised risk factors of tuberculosis. No study has reported the magnitude of diabetes mellitus among tuberculosis patients in Uganda, one of the countries with a high burden of tuberculosis.

Methods

This was a cross-sectional study conducted among 260 consenting adult patients with a confirmed diagnosis of tuberculosis admitted on the pulmonology wards of Mulago national referral and teaching hospital in Kampala, Uganda to determine the prevalence of diabetes mellitus and associated clinical factors. Laboratory findings as well as the socio-demographic and clinical data collected using a validated questionnaire was obtained. Point of care random blood sugar (RBS) testing was performed on all the patients prior to initiation of anti tuberculosis treatment. Diabetes mellitus was diagnosed if the RBS level was ≥ 200mg/dl in the presence of the classical symptoms of diabetes mellitus.

Results

The prevalence of diabetes mellitus among the admitted patients with tuberculosis was 8.5%. Only 5 (1.9%) patients with TB had a known diagnosis of diabetes mellitus at enrolment. Majority of the study participants with TB-DM co-infection had type 2 diabetes mellitus (n=20, 90.9%).

At bivariate analysis, raised mean ALT concentrations of ≥80 U/L were associated with DM (OR-6.1, 95% CI 1.4-26.36, p=0.032) and paradoxically, HIV co-infection was protective of DM (OR-0.32, 95% CI 0.13-0.79, P=0.016). The relationship between DM and HIV as well as that with ALT remained statistically significant at multivariate analysis (HIV: OR- 0.17 95%CI 0.06-0.51, p=0.002 and ALT: OR-11.42 95%CI 2.15-60.59, p=0.004).

Conclusion

This study demonstrates that diabetes mellitus is common among hospitalized tuberculosis patients in Uganda. The significant clinical predictors associated with diabetes mellitus among tuberculosis patients were HIV co-infection and raised mean serum alanine transaminase concentrations.